Annual CFO
-$1.11 M
-$15.43 M-107.77%
December 1, 2023
Summary
- As of February 8, 2025, IRD annual cash flow from operations is -$1.11 million, with the most recent change of -$15.43 million (-107.77%) on December 1, 2023.
- During the last 3 years, IRD annual CFO has risen by +$5.68 million (+83.64%).
- IRD annual CFO is now -107.77% below its all-time high of $14.31 million, reached on December 1, 2022.
Performance
IRD Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$5.13 M
+$2.16 M+29.65%
September 1, 2024
Summary
- As of February 8, 2025, IRD quarterly cash flow from operations is -$5.13 million, with the most recent change of +$2.16 million (+29.65%) on September 1, 2024.
- Over the past year, IRD quarterly CFO has increased by +$586.00 thousand (+10.25%).
- IRD quarterly CFO is now -117.82% below its all-time high of $28.79 million, reached on December 1, 2022.
Performance
IRD Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$13.59 M
-$2.13 M-18.56%
September 1, 2024
Summary
- As of February 8, 2025, IRD TTM cash flow from operations is -$13.59 million, with the most recent change of -$2.13 million (-18.56%) on September 1, 2024.
- Over the past year, IRD TTM CFO has dropped by -$10.41 million (-327.09%).
- IRD TTM CFO is now -158.75% below its all-time high of $23.13 million, reached on September 1, 2023.
Performance
IRD TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
IRD Cash From Operations Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -107.8% | +10.3% | -327.1% |
3 y3 years | +83.6% | +9.1% | +29.8% |
5 y5 years | +69.0% | +9.1% | +29.8% |
IRD Cash From Operations Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -107.8% | +94.3% | -117.8% | +29.6% | -158.8% | +32.5% |
5 y | 5-year | -107.8% | +94.3% | -117.8% | +29.6% | -158.8% | +32.5% |
alltime | all time | -107.8% | +94.3% | -117.8% | +29.6% | -158.8% | +32.5% |
Opus Genetics Cash From Operations History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | -$5.13 M(-29.6%) | -$13.59 M(+18.6%) |
Jun 2024 | - | -$7.29 M(+27.6%) | -$11.46 M(+260.2%) |
Mar 2024 | - | -$5.72 M(-225.7%) | -$3.18 M(+186.2%) |
Dec 2023 | -$1.11 M(-107.8%) | $4.55 M(-251.4%) | -$1.11 M(-104.8%) |
Sep 2023 | - | -$3.00 M(-403.6%) | $23.13 M(+6.9%) |
Jun 2023 | - | $989.00 K(-127.1%) | $21.64 M(+28.5%) |
Mar 2023 | - | -$3.65 M(-112.7%) | $16.84 M(+17.6%) |
Dec 2022 | $14.31 M | $28.79 M(-740.1%) | $14.31 M(-171.1%) |
Sep 2022 | - | -$4.50 M(+18.1%) | -$20.12 M(+4.8%) |
Jun 2022 | - | -$3.81 M(-38.3%) | -$19.21 M(-2.6%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2022 | - | -$6.17 M(+9.3%) | -$19.73 M(+1.8%) |
Dec 2021 | -$19.37 M(+185.0%) | -$5.65 M(+57.5%) | -$19.37 M(+7.1%) |
Sep 2021 | - | -$3.58 M(-17.2%) | -$18.08 M(+16.3%) |
Jun 2021 | - | -$4.33 M(-25.5%) | -$15.55 M(+31.0%) |
Mar 2021 | - | -$5.81 M(+33.4%) | -$11.88 M(+74.7%) |
Dec 2020 | -$6.80 M(+89.2%) | -$4.36 M(+312.7%) | -$6.80 M(+178.7%) |
Sep 2020 | - | -$1.06 M(+62.2%) | -$2.44 M(+76.4%) |
Jun 2020 | - | -$651.00 K(-11.1%) | -$1.38 M(+88.9%) |
Mar 2020 | - | -$732.00 K | -$732.00 K |
Dec 2019 | -$3.59 M | - | - |
FAQ
- What is Opus Genetics annual cash flow from operations?
- What is the all time high annual CFO for Opus Genetics?
- What is Opus Genetics annual CFO year-on-year change?
- What is Opus Genetics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Opus Genetics?
- What is Opus Genetics quarterly CFO year-on-year change?
- What is Opus Genetics TTM cash flow from operations?
- What is the all time high TTM CFO for Opus Genetics?
- What is Opus Genetics TTM CFO year-on-year change?
What is Opus Genetics annual cash flow from operations?
The current annual CFO of IRD is -$1.11 M
What is the all time high annual CFO for Opus Genetics?
Opus Genetics all-time high annual cash flow from operations is $14.31 M
What is Opus Genetics annual CFO year-on-year change?
Over the past year, IRD annual cash flow from operations has changed by -$15.43 M (-107.77%)
What is Opus Genetics quarterly cash flow from operations?
The current quarterly CFO of IRD is -$5.13 M
What is the all time high quarterly CFO for Opus Genetics?
Opus Genetics all-time high quarterly cash flow from operations is $28.79 M
What is Opus Genetics quarterly CFO year-on-year change?
Over the past year, IRD quarterly cash flow from operations has changed by +$586.00 K (+10.25%)
What is Opus Genetics TTM cash flow from operations?
The current TTM CFO of IRD is -$13.59 M
What is the all time high TTM CFO for Opus Genetics?
Opus Genetics all-time high TTM cash flow from operations is $23.13 M
What is Opus Genetics TTM CFO year-on-year change?
Over the past year, IRD TTM cash flow from operations has changed by -$10.41 M (-327.09%)